HealthMedical Breakthrough
Experimental Pill Nearly Doubles Pancreatic Cancer Survival
A new experimental pill nearly doubles survival for advanced pancreatic cancer patients, targeting the long-undruggable KRAS mutation.
—5 min read
Category
2 articles
A new experimental pill nearly doubles survival for advanced pancreatic cancer patients, targeting the long-undruggable KRAS mutation.
AZ Sint-Jan Brugge becomes first in Europe to implant a tricuspid heart valve via the jugular vein, offering hope for patients too frail for surgery.